Data / Drug companies / QPharma, Inc.
QPharma, Inc.: 120 products in the FDA NDC directory, labeler code 42708
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
QPharma, Inc. (labeler code 42708) lists 120 products in the FDA National Drug Code Directory, covering 48 finished drugs by generic name. By type: 120 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on December 6, 2025.
The request: Watch QPharma, Inc. (FDA labeler code 42708): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 42708
- Products in commercial distribution
- 120
- Packages
- 121
- Finished drugs by generic name
- 48
- Prescription products
- 120
- Over the counter products
- 0
- Started marketing in the last 12 months
- 1
- Products with a marketing end date set
- 1
- Earliest marketing start
- January 12, 1973
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 118 | 98.3% |
| Other unapproved drugs | 1 | 0.8% |
| Authorized generics (NDA) | 1 | 0.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 120 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 47 | 39.2% |
| Tablet | 43 | 35.8% |
| Capsule | 16 | 13.3% |
| Capsule, delayed release | 5 | 4.2% |
| Tablet, delayed release | 3 | 2.5% |
| Capsule, extended release | 2 | 1.7% |
| Tablet, film coated, extended release | 1 | 0.8% |
| Tablet, coated | 1 | 0.8% |
| Capsule, gelatin coated | 1 | 0.8% |
| Tablet, extended release | 1 | 0.8% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Amlodipine Besylate | 42708-204 | Tablet | Generic drugs (ANDA) | December 6, 2025 |
| Metformin hydrochloride | 42708-203 | Tablet, film coated | Generic drugs (ANDA) | August 25, 2025 |
| Metformin hydrochloride | 42708-202 | Tablet, film coated | Generic drugs (ANDA) | August 25, 2025 |
| Fluoxetine | 42708-200 | Capsule | Generic drugs (ANDA) | July 11, 2025 |
| Metoprolol tartrate | 42708-198 | Tablet | Generic drugs (ANDA) | January 17, 2024 |
| Meclizine Hydrochloride | 42708-189 | Tablet | Generic drugs (ANDA) | April 22, 2022 |
| Prednisone | 42708-195 | Tablet | Generic drugs (ANDA) | March 28, 2022 |
| NITROFURANTOIN (monohydrate/macrocrystals) | 42708-184 | Capsule | Generic drugs (ANDA) | February 22, 2022 |
| Prednisone | 42708-186 | Tablet | Generic drugs (ANDA) | September 1, 2021 |
| Prednisone | 42708-166 | Tablet | Generic drugs (ANDA) | September 1, 2021 |
| Lisinopril | 42708-176 | Tablet | Generic drugs (ANDA) | June 1, 2021 |
| Cyproheptadine hydrochloride | 42708-187 | Tablet | Generic drugs (ANDA) | February 24, 2021 |
| Omeprazole | 42708-170 | Capsule, delayed release | Generic drugs (ANDA) | July 1, 2019 |
| Prednisone | 42708-136 | Tablet | Generic drugs (ANDA) | March 7, 2019 |
| Atorvastatin Calcium | 42708-144 | Tablet, film coated | Generic drugs (ANDA) | December 23, 2018 |
| Atorvastatin Calcium | 42708-141 | Tablet, film coated | Generic drugs (ANDA) | December 23, 2018 |
| Benzonatate | 42708-171 | Capsule | Generic drugs (ANDA) | December 21, 2018 |
| Losartan Potassium and Hydrochlorothiazide | 42708-193 | Tablet, film coated | Generic drugs (ANDA) | February 15, 2018 |
| Cyclobenzaprine hydrochloride | 42708-197 | Tablet, film coated | Generic drugs (ANDA) | May 31, 2017 |
| Lisinopril | 42708-165 | Tablet | Generic drugs (ANDA) | May 12, 2017 |
| Lisinopril | 42708-154 | Tablet | Generic drugs (ANDA) | May 12, 2017 |
| Atorvastatin Calcium | 42708-005 | Tablet, film coated | Generic drugs (ANDA) | May 4, 2017 |
| Atorvastatin Calcium | 42708-004 | Tablet, film coated | Generic drugs (ANDA) | May 4, 2017 |
| Atorvastatin Calcium | 42708-003 | Tablet, film coated | Generic drugs (ANDA) | May 4, 2017 |
| Benzonatate | 42708-082 | Capsule | Generic drugs (ANDA) | March 22, 2017 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.